ATP1B3 and neoplasm: Whole-mount imaging showed that GFP expression was retained in primary tumors (Fig. 4e), and quantification by flow cytometry showed that >90% of CD298+MHC-I− human PDX tumor cells retained GFP signal (Fig. 4f).